Format

Send to

Choose Destination
Trends Immunol. 2018 Oct 27. pii: S1471-4906(18)30186-8. doi: 10.1016/j.it.2018.10.002. [Epub ahead of print]

A Portrait of CXCR5+ Follicular Cytotoxic CD8+ T cells.

Author information

1
Department of Immunology and Infectious Diseases, The John Curtin School of Medical Research, The Australian National University, Acton, ACT, Australia; Shandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China; China-Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: di.yu@anu.edu.au.
2
Institute of Immunology, Third Military Medical University, Chongqing, China. Electronic address: yelilinlcmv@tmmu.edu.cn.

Abstract

CD8+ T cells differentiate into multiple effector and memory subsets to carry out immune clearance of infected and cancerous cells and provide long-term protection. Recent research identified a CXCR5+Tcf1+Tim-3- subset that localizes in, or proximal to, B cell follicles in secondary lymphoid organs of mice, non-human primates, and humans, hereby termed follicular cytotoxic T (TFC) cells. With remarkable similarity to follicular helper T (TFH) cells, TFC differentiation is dependent on transcription factors E2A, Bcl6, and Tcf1, but inhibited by other regulators, including Blimp1, Id2, and Id3. This review summarizes the phenotype, function, and differentiation of this new subset. Owing to its follicular location and self-renewal capability, we propose immunotherapeutic strategies to target TFC cells to potentially treat certain cancers and chronic infections such as HIV-1.

PMID:
30377045
DOI:
10.1016/j.it.2018.10.002

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center